DeutschNewstral
Article
The New York Times on 2019-06-13 17:32
Depo-Provera, an Injectable Contraceptive, Does Not Raise H.I.V. Risk
Related news
- GHiv Risk by Injecting Depo-ProveraGuardian Liberty Voice
No Depo-provera, HIV link — researchherald.co.zw- 25 years of uncertainty over for depo-provera usersherald.co.zw
Injectable male contraceptive tested successfully on monkeysengadget- WHO revises Depo Provera guidelinesherald.co.zw
- NRundu hospitals out of Depo Proveraneweralive.na
- SAn injectable contraceptive, with no hormonal side effects?studentnewspaper.org
- Who Owns H.I.V.-Prevention Drugs? The Taxpayers, U.S. SaysThe New York Times
- Someday, an Arm Implant May Prevent H.I.V. Infection for a YearThe New York Times
- New Strawberry-Flavored H.I.V. Drugs for Babies Are Offered at $1 a DayThe New York Times
- Intensive Anti-H.I.V. Efforts Meet With Mixed Success in AfricaThe New York Times
Injectable antiretroviral drugs welcome move for Ugandamonitor.co.ug- DECHO Trial: No Relationship Between Hormonal Contraceptive And HIV Riskdailyguidenetwork.com
- Global Health: Gilead Will Donate Truvada to U.S. for H.I.V. PreventionThe New York Times
- Zimbabwe introduces injectable HIV drugherald.co.zw
- Global Health: Vaccines Against H.I.V., Malaria and Tuberculosis Unlikely, Study SaysThe New York Times
- H.I.V. Is Coming to Rural AmericaThe New York Times
- The City Losing Its Children to H.I.V.The New York Times
- DDKT Intensifies Contraceptive Campaigndailyguideafrica.com
- TA Contraceptive Conundrumthegeorgeanne.com